Headline News about Anaptysbio Inc
The Analyst Landscape: 7 Takes On AnaptysBio
May 10, 2024
Via Benzinga
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
April 11, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
Unveiling 4 Analyst Insights On AnaptysBio
April 01, 2024
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 09, 2023
Via Benzinga
HC Wainwright Sees 40% Upside For This Once Battered Stock With Pipeline Turnaround
September 19, 2022
Via Benzinga
AnaptysBio Sells Royalty Interest In Cancer Drug For $45M
September 12, 2022
Via Benzinga
Raymond James Initiates AnaptysBio With ~42% Upside, Despite Trial Setback
September 02, 2022
Via Benzinga
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 06, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
January 06, 2023
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 05, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2022
September 01, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.